CD47 and breast cancer: In this context, we previously demonstrated that CD47 and PD-L1, two putative immune checkpoints involved in tumor escape, are more frequently expressed on CTCs compared to the corresponding primary or metastatic tumor tissues of BC patients, and that these CTC populations predict for poor patient outcomes [26].